Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PHSYX vs. HRTS: which is better?

Bottom line

PHSYX vs HRTS: the short answer

PHSYX (Putnam Global Health Care Fund) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 62% by weight.

But PHSYX is far broader, holding 115 positions to 45 for HRTS, so beyond the top names it adds exposure HRTS doesn't have.

HRTS is cheaper at 0.75% vs 0.79% — a difference of $4.00 a year per $10,000 invested.

Over one year, HRTS returned +23.6% vs +1.5% for PHSYX (reporting dates differ).

Updated Nov 19, 2026

PHSYX vs HRTS side by side

PHSYXHRTS
TypeMutual fundETF
Fund familyFranklin TempletonInnovator
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.79%0.75%
Annual cost per $10k$79$75
10-yr cost on $10k (prospectus)$978$1,168
Max front load0%None
12b-1 fee0%0%
1-yr return+1.5%+23.6%
5-yr return (annualized)+8.1%—
10-yr return (annualized)+7.8%—
Best quarter—+15.8%
Worst quarter—−12.4%
Net assets (fund)$1.5B$51.9M
Number of holdings11545
Portfolio turnover67%4%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

16 of PHSYX's top 25 holdings also appear in HRTS's top 25.

Shared top holdings
HoldingPHSYXHRTS
Eli Lilly & Co.13.15%11.52%
Johnson & Johnson8.46%3.59%
UnitedHealth Group, Inc.6.93%5.24%
AbbVie, Inc.6.05%2.40%
Novartis AG5.13%3.38%
Merck & Co., Inc.4.88%4.27%
AstraZeneca plc4.67%4.00%
Thermo Fisher Scientific, Inc.4.50%3.97%
Edwards Lifesciences Corp.2.80%1.75%
Gilead Sciences, Inc.2.63%3.43%
McKesson Corp.2.14%1.71%
Vertex Pharmaceuticals, Inc.1.97%2.93%
Novo Nordisk A/S1.90%5.24%
Bristol-Myers Squibb Co.1.75%2.09%
Dexcom, Inc.1.64%1.92%

Source: SEC Form N-PORT

PHSYX top 10

  1. Eli Lilly & Co. — 13.15%
  2. Johnson & Johnson — 8.46%
  3. UnitedHealth Group, Inc. — 6.93%
  4. AbbVie, Inc. — 6.05%
  5. Novartis AG — 5.13%
  6. Merck & Co., Inc. — 4.88%
  7. AstraZeneca plc — 4.67%
  8. Thermo Fisher Scientific, Inc. — 4.50%
  9. Intuitive Surgical, Inc. — 4.04%
  10. Sanofi SA — 3.23%

HRTS top 10

  1. Eli Lilly & Co — 11.52%
  2. UnitedHealth Group Inc — 5.24%
  3. Novo Nordisk A/S — 5.24%
  4. Roche Holding AG — 4.50%
  5. Merck & Co Inc — 4.27%
  6. AstraZeneca PLC — 4.00%
  7. Thermo Fisher Scientific Inc — 3.97%
  8. Johnson & Johnson — 3.59%
  9. Gilead Sciences Inc — 3.43%
  10. Novartis AG — 3.38%

FAQ

What is the difference between PHSYX and HRTS?
PHSYX (Putnam Global Health Care Fund) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 62% by weight. But PHSYX is far broader, holding 115 positions to 45 for HRTS, so beyond the top names it adds exposure HRTS doesn't have.
Which is cheaper, PHSYX or HRTS?
HRTS has the lower expense ratio (0.75%).
Should I own both PHSYX and HRTS?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.